A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Totus Medicines
Totus Medicines
National Institutes of Health Clinical Center (CC)
National Cancer Institute, Naples
Actuate Therapeutics Inc.
Acrivon Therapeutics
Curis, Inc.
Artios Pharma Ltd
Ensem Therapeutics
Eli Lilly and Company
AstraZeneca
EMD Serono
EMD Serono
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Memorial Sloan Kettering Cancer Center
Novartis
Revolution Medicines, Inc.
Faeth Therapeutics
Kura Oncology, Inc.
AstraZeneca
Zhuhai Yufan Biotechnologies Co., Ltd
Johns Hopkins University
National University Hospital, Singapore
AstraZeneca
Hangzhou Polymed Biopharmaceuticals, Inc.
VA Office of Research and Development
AstraZeneca
Swiss Cancer Institute
Revolution Medicines, Inc.
Minia University
Incyte Corporation
Case Comprehensive Cancer Center
Zhuhai Yufan Biotechnologies Co., Ltd
Merck KGaA, Darmstadt, Germany
Nimbus Therapeutics
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Pfizer
Novartis
EMD Serono
Novartis
Regor Pharmaceuticals Inc.
Aadi Bioscience, Inc.
Incyte Corporation
Bayer
Haihe Biopharma Co., Ltd.
Massachusetts General Hospital
Pfizer
SecuraBio
Pfizer
Institut de Cancérologie de Lorraine
Asana BioSciences